With the aid of 11 neutralizing monoclonal antibodies which were investigated in four different neutralization tests, evidence was provided that several unrelated epitopes for neutralizing antibodies exist on the surface of poliovirus type 1. All monoclonal antibodies were able to neutralize poliovirus infectivity prior to and after virus adsorption to host cells. The quantitative enzyme-linked immunosorbent assay is introduced as a second independent system for the determination of antibody specificity. Antibodies could be divided into four groups according to their reaction patterns.
The application of monoclonal antibodies (mAbs) to investigate poliovirus antigens has led to some interesting new findings. Ferguson et al. (1981) showed that with the aid of mAbs against poliovirus type 3 that D-antigenicity of infectious virus (Le Bouvier, 1959 ) appeared also on 80S empty capsids to which previously a different type of antigen, the so-called C-antigen, had been attributed (Le Bouvier, 1959) . Icenogle et al. (1981) and Emini et al. (1982) could demonstrate that neutralizing mAbs (Nt-mAbs) against poliovirus type 1 reacted with 80S and 14S particles, but not with structures smaller than 14S. With the aid of bifunctional agents, Emini et al. (1982) cross-linked Nt-mAbs to the viral surface, where they bound predominantly to VP1. It was found that Nt-mAbs reacted intratypically with different strains of the same serotype (Icenogle et al., 1981 ; Osterhaus et al., 1981 ; Emini et al., 1982) , although mAbs were produced which neutralized 1000-fold better the strain against which they were raised (Osterhaus et al., 1981) . We were interested to know how many different epitopes for Nt-mAbs existed on poliovirus type 1 and whether they could be characterized biochemically and biologically. For biochemical Characterization, we chose a quantitative enzyme-linked immunosorbent assay (ELISA) with virus particles, empty capsids and other particles obtained by physical and chemical treatment. As a first step in biological characterization we investigated 11 Nt-mAbs in four different neutralization systems.
HeLa $3 cells used for virus production were grown in Eagle's minimal essential medium (MEM, Joklik's modified), supplemented with 5~o newborn calf serum (NCS) (Boehringer Mannheim), HeLa monolayer ceils and GMK cells (kindly provided by Professor H. Lennartz from the Institut fiir Impfwesen und Virologic, Hamburg, F.R.G.) were grown in Earle's MEM supplemented with 5 ~ NCS. P3/NS-1/1-Ag4-1 mouse myeloma cells were grown in Dulbecco's modified MEM supplemented with 15 ~ foetal calf serum (FCS). Hybridomas were selected in HAT medium and later grown in HY medium as described by Kennett et al. (1978) . Phosphatebuffered saline (PBS) pH 7-2, was used. Poliovirus, type 1, strains Mahoney and Sabin LSc2ab (this strain was kindly provided by Dr R. Mauler, Behringwerke, Marburg, F.R.G., at one of its early passages), poliovirus, type 2, MEF-1 and poliovirus, type 3, Saukett (Drzeniek, 1975; Hamann et al., 1978) were used throughout. Infectious (standard) poliovirus particles (SP) and naturally occurring empty capsids (NEC) were prepared as previously described (Drzeniek & Bilello, 1974; Yamaguchi-Koll et al., 1975) . SP and NEC were stored at -20 °C in 3 M-CsC1. Quantitative determination of SP and NEC was done spectrophotometrically, using extinction coefficients for SP of 1~ = A26 o 74 and for NEC of 1~ = A2s0 16-2 according to Heukeshoven & Dernick (1980) . Physical and chemical treatments of SP and NEC were done as follows: heated virus SP type 1, Mahoney (1 mg protein/ml) was diluted 1 : 20 in PBS and kept in a heating block or a water-bath for 30min at 56 °C; it was then diluted 10-fold with ice-cold PBS and immediately used in ELISA. For formaldehyde treatment SP and NEC of 1 mg protein/ml were diluted 1:200 in freshly prepared 3.7 ~ formaldehyde solution in PBS, kept at room temperature for 20 min and immediately used for ELISA.
Hybridomas were produced as described by Kennett et al. (1978) . Immunization of mice and screening for poliovirus-specific antibodies by ELISA were performed with SP type 1, Mahoney. Positive cultures were cloned in semi-solid agarose and propagated in tissue culture flasks. The indirect solid-phase ELISA of Katze & Crowell (1980) was applied with minor modifications. Fifty Ixl/well of antigen solution in PBS were used; incubations of culture supernatant or peroxidase-labelled rabbit anti-mouse Ig (Dako, Copenhagen, Denmark) were carried out at 37 °C for 2 h in a humid atmosphere. Results were read with a multiscan ELISA reader (Flow Laboratories). Four varieties of neutralization test were performed. Besides the standard microneutralization test (see footnote to Table 1 ), a microplate adaptation of the neutralization test with virus pre-adsorbed to cells (Mandel, 1967) was applied. Briefly, freshly trypsinized cells were seeded into microplates at 104/well, cultivated overnight at 37 °C and cooled to 4 °C for 30 min. Fifty ~tl of SP (1000 p.f.u./ml as determined by the plaque assay of Bishop & Koch, 1969) in HY medium was added and the plates were left at 4 °C for 1 h, 100 ~tl of cold culture supernatant of hybridomas was added and the plates were left at 4 °C for a further 2 h. Then the plates were transferred to 37 °C and results read after 2 or 3 days. Both tests were performed with two different host cell systems each, HeLa cells and GMK cells. Controls and interpretation of results were as described in the footnote to Table 1 .
Neutralizing capacities of Nt-mAbs were determined by the standard microneutralization test (Table 1) . None of 11 Nt-mAbs neutralized poliovirus types 2 or 3. Three Nt-mAbs neutralized equally well the Sabin and Mahoney strains of poliovirus type 1. Six Nt-mAbs neutralized only the Mahoney strain and two Nt-mAbs neutralized both strains Mahoney and Sabin of poliovirus type 1, but the former was neutralized more efficiently.
Good agreement was found between ELISA and neutralization tests with different types and strains of poliovirus. The antibodies did not react in either assay with poliovirus types 2 and 3 and those antibodies which did not neutralize the Sabin strain of poliovirus type l did not react with this strain in ELISA. Antibodies that neutralized both Sabin and Mahoney strains to the same extent showed equal reaction in ELISA with both antigens, and if the ability of an antibody to neutralize the Sabin strain was reduced as compared with strain Mahoney, the ELISA reaction was also reduced significantly.
Four groups of Nt-mAbs were identified by ELISA ( Table 2 ). The six mAbs belonging to the first group recognized only the Mahoney strain, but reacted well with NEC, heated virus and formaldehyde-treated virus. The two mAbs of the second group reacted less efficiently with strain Sabin as compared with strain Mahoney; they did not bind to heated virus; their reaction with NEC was faint and formaldehyde treatment largely destroyed their epitopes. Group III antibodies reacted equally well with both strains of poliovirus type 1. They did not recognize heated virus and they bound only weakly to NEC. Formaldehyde treatment affected their epitopes, but not as dramatically as with group II (Table 2 ). The antibody of group IV differed from those of group III by two criteria: it recognized heated virus and its reaction with NEC was much stronger. Mandel (1967) showed with conventional antisera that poliovirus may be neutralized even after adsorption to the host cell provided that immediate virus penetration is inhibited by low temperature. This ability of conventional antisera reflects a major property of an antibody mixture and does not necessarily apply to every neutralizing antibody. We could demonstrate that all four different groups of Nt-mAbs were able to neutralize poliovirus prior to as well as after virus adsorption to the cell. This indicates that neither virus aggregation nor precipitation * Serial fourfold dilutions of hybridoma culture supernatant were made in duplicate series in HY medium and 100 rtl samples were applied to individual wells of microtitre plates. Fifty ~tl of SP in HY medium (1000 p.f.u./ml) was added and the plates incubated for 2 h at 37 °C in a CO~ incubator. Then, l04 cells were added in 100 p.1 volume. Plates were incubated for 2 days (with HeLa cells) or 3 days (with GMK cells) before results could be read. Culture fluid was discarded and adherent cells were fixed and stained for 15 min with crystal violet (0.1%) formaldehyde (3.7 ~) in PBS. Then plates were washed and results read with the naked eye. Positive controls were uninfected cells; negative controls were infected ceils incubated with culture medium instead of hybridoma supernatant. The highest dilution of hybridoma culture supernatant that in both series led to complete neutralization of the p.f.u, applied, and therefore resembled uninfected cell controls, was assumed to indicate the titration endpoint. The data obtained were extrapolated to 1 ml of undiluted culture supernatant and are given in the * Reactions of mAbs used in this study in both neutralization tests and ELISA are shown. The intensity of a reaction is expressed in grades: reaction greater than 80~ of that with poliovirus type 1, Mahoney (+ + ); (+) reaction in ELISA 25 to 50% or neutralization 1 log~ 0 unit less than (+ + ); 6 to 20~ reaction (+); reaction 5 ~ or less (-); no reaction (--).
nor any other way of blocking virus binding to its cell receptor are the main mechanisms by which these antibodies can inhibit viral infections. The behaviour of all our antibodies was not altered when neutralization tests were performed with GMK cells instead of HeLa cells as the host cell system. Therefore, it is likely that all our antibodies neutralize poliovirus by the same mechanisms. The four groups of mAbs were obtained by two independent cell fusions with spleens of two mice each. Although the agreement between the total number of spleens used for the production of mAbs and the number of groups of antibodies identified could be accidental, it should be considered that many independent cell fusions might be required to obtain the full spectrum of Nt-mAbs against poliovirus type 1, Mahoney.
